Pyrimidines are essential for the cell survival and proliferation of living parasitic organisms, such as Helicobacter pylori, Plasmodium falciparum and Schistosoma mansoni, that are able to impact upon human health. Pyrimidine building blocks, in human cells, are synthesised via both de novo biosynthesis and salvage pathways, the latter of which is an effective way of recycling pre-existing nucleotides. As many parasitic organisms lack pyrimidine salvage pathways for pyrimidine nucleotides, blocking de novo biosynthesis is seen as an effective therapeutic means to selectively target the parasite without effecting the human host. Dihydroorotate dehydrogenase (DHODH), which is involved in the de novo biosynthesis of pyrimidines, is a validated target for anti-infective drug research. Recent advances in the DHODH microorganism field are discussed herein, as is the potential for the development of DHODH-targeted therapeutics.

Dihydroorotate dehydrogenase inhibitors in anti-infective drug research

Boschi D.
First
;
Pippione A. C.;Sainas S.;Lolli M. L.
Last
2019-01-01

Abstract

Pyrimidines are essential for the cell survival and proliferation of living parasitic organisms, such as Helicobacter pylori, Plasmodium falciparum and Schistosoma mansoni, that are able to impact upon human health. Pyrimidine building blocks, in human cells, are synthesised via both de novo biosynthesis and salvage pathways, the latter of which is an effective way of recycling pre-existing nucleotides. As many parasitic organisms lack pyrimidine salvage pathways for pyrimidine nucleotides, blocking de novo biosynthesis is seen as an effective therapeutic means to selectively target the parasite without effecting the human host. Dihydroorotate dehydrogenase (DHODH), which is involved in the de novo biosynthesis of pyrimidines, is a validated target for anti-infective drug research. Recent advances in the DHODH microorganism field are discussed herein, as is the potential for the development of DHODH-targeted therapeutics.
2019
183
111681
111701
https://www.sciencedirect.com/science/article/pii/S0223523419308311
Antiviral; Aspergillus fumigatus; Babesia bovis; Babesia caballi; Bioisosterism; Brequinar; Dihydroorotate dehydrogenase (DHODH) inhibitors; hDHODH; Helicobacter pilory; Leflunomide; Leishmania; Malaria; Plasmodium falciparum; Plasmodium vivax; Pseudomonas aeruginosa; Schistosoma mansoni; Teriflunomide; Theileria equi; Toxoplasma gondii; Trypanosoma; Animals; Drug Discovery; Humans; Oxidoreductases Acting on CH-CH Group Donors; Plasmodium falciparum; Anti-Infective Agents; Enzyme Inhibitors; Pyrimidines
Boschi D.; Pippione A.C.; Sainas S.; Lolli M.L.
File in questo prodotto:
File Dimensione Formato  
review DHODH parassiti.pdf

Accesso riservato

Descrizione: Articolo principale
Tipo di file: PDF EDITORIALE
Dimensione 3.68 MB
Formato Adobe PDF
3.68 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1807154
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 50
social impact